Dilon reports positive findings for MBI

01/21/2013 | AuntMinnie.com (free registration)

Dilon Diagnostics is reporting positive results for molecular breast imaging from two studies. The first study showed MBI has a higher sensitivity in finding cancers compared with mammography and ultrasound. In the second study, MBI performed comparably with MRI in identifying cancers.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA